Tibet Duo Rui Pharmaceutical Co Ltd
SZSE:301075
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Tibet Duo Rui Pharmaceutical Co Ltd
SZSE:301075
|
CN |
|
R
|
Rayhoo Motor Dies Co Ltd
SZSE:002997
|
CN |
|
A
|
Autoline Industries Ltd
NSE:AUTOIND
|
IN |
|
Gemini Group Global Corp
OTC:GMNI
|
US |
|
K
|
Kemira Oyj
XBER:KEM
|
FI |
|
Velocity Composites PLC
LSE:VEL
|
UK |
|
E
|
Ewein Bhd
KLSE:EWEIN
|
MY |
|
Mitsui E&S Holdings Co Ltd
OTC:MIESF
|
JP |
|
Rushnet Inc
OTC:RSHN
|
US |
|
L
|
Linmon Media Ltd
HKEX:9857
|
CN |
|
Ifa Systems AG
XETRA:IS8
|
DE |
|
Vanta Bioscience Ltd
BSE:540729
|
IN |
|
W
|
Wavedancer Inc
NASDAQ:WAVD
|
US |
|
Stitch Fix Inc
NASDAQ:SFIX
|
US |
|
Ufp Industries Inc
NASDAQ:UFPI
|
US |
Bankruptcy Probability
Tibet Duo Rui Pharmaceutical Co Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Tibet Duo Rui Pharmaceutical Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
T
|
Tibet Duo Rui Pharmaceutical Co Ltd
SZSE:301075
|
5B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Tibet Duo Rui Pharmaceutical Co Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Tibet Duo Rui Pharmaceutical Co Ltd has total debt of 483.4m CNY. This includes both short-term (309.4m CNY) and long-term (174m CNY) debt.
You can find a full breakdown on its Balance Sheet.
